2013      2012     2011     2010     2009     2008     2007     2006     2005     2004     2003     journal covers          PubMed Search  

1. Achkar, J. M., A. Casadevall, and A. Glatman-Freedman. 2007. Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches. Expert Rev Anti Infect Ther 5:461-74.  

2. Al-Sayyed, B., S. Piperdi, X. Yuan, A. Li, G. S. Besra, W. R. Jacobs, Jr., A. Casadevall, and A. Glatman-Freedman. 2007. Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51. Tuberculosis (Edinb). 

3. Alvarez, M., and A. Casadevall. 2007. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol 8:16. 

4. Casadevall, A., H. Goldstein, and E. Dadachova. 2007. Targeting host cells harbouring viruses with radiolabeled antibodies. Expert Opin Biol Ther 7:595-7.  

5. Casadevall, A., and L. A. Pirofski. 2007. Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryot Cell. 

6. Casadevall, A., and L. A. Pirofski. 2007. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect Immun. 

7. Chaskes S, Frases S, Cammer M, Gerfen G, Casadevall A. 2007. Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans. J Clin Microbiol. 

8. Dadachova, E., R. A. Bryan, X. Huang, T. Moadel, A. D. Schweitzer, P. Aisen, J. D. Nosanchuk, and A. Casadevall. 2007. Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi. PLoS ONE 2:e457. 

9. Dadachova, E., R. A. Bryan, X. Huang, G. Ortiz, T. Moadel, and A. Casadevall. 2007. Comparative Evaluation of Capsular Polysaccharide-Specific IgM and IgG Antibodies and F(ab')2 and Fab Fragments as Delivery Vehicles for Radioimmunotherapy of Fungal Infection. Clin Cancer Res 13:5629s-35s. 

10. Dadachova, E., X. G. Wang, and A. Casadevall. 2007. Targeting the virus with radioimmunotherapy in virus-associated cancers. Cancer Biother Radiopharm 22:303-8. 

11. Davis, J., W. Y. Zheng, A. Glatman-Freedman, J. A. Ng, M. R. Pagcatipunan, H. Lessin, A. Casadevall, and D. L. Goldman. 2007. Serologic evidence for regional differences in pediatric cryptococcal infection. Pediatr Infect Dis J 26:549-51.  

12. De Jesus, M., E. Hackett, M. Durkin, P. Connolly, A. Casadevall, R. Petraitiene, T. J. Walsh, and L. J. Wheat. 2007. Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 14:624-7. 

13. Eisenman HC, Mues M, Weber SE, Frases S, Chaskes S, Gerfen G, Casadevall A. 2007.Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA. Microbiology.  

14. Eisenman HC, Casadevall A, McClelland EE. 2007. New Insights on the Pathogenesis of Invasive Cryptococcus neoformans Infection. Curr Infect Dis Rep. 

15. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. 2007. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell. 

16. Frases, S., A. Salazar, E. Dadachova, and A. Casadevall. 2007. Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis. Appl Environ Microbiol 73:615-21.  

17. Howell, R. C., E. Revskaya, V. Pazo, J. D. Nosanchuk, A. Casadevall, and E. Dadachova. 2007. Phage Display Library Derived Peptides that Bind to Human Tumor Melanin as Potential Vehicles for Targeted Radionuclide Therapy of Metastatic Melanoma. Bioconjug Chem. 

18. Macura, N., T. Zhang, and A. Casadevall. 2007. Dependence of macrophage phagocytic efficacy on antibody concentration. Infect Immun 75:1904-15. 

19. Martinez, L. R., and A. Casadevall. 2007. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol 73:4592-601. 

20. Martinez, L. R., P. Ntiamoah, A. Casadevall, and J. D. Nosanchuk. 2007. Caspofungin reduces the incidence of fungal contamination in cell culture. Mycopathologia. 

21. Martinez, L. R., P. Ntiamoah, A. Gacser, A. Casadevall, and J. D. Nosanchuk. 2007. VORICONAZOLE INHIBITS MELANIZATION IN Cryptococcus neoformans. Antimicrob Agents Chemother. 

22. McFadden, D. C., B. C. Fries, F. Wang, and A. Casadevall. 2007. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell 6:1464-73. 

23. Mylonakis, E., A. Casadevall, and F. M. Ausubel. 2007. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 3:e101. 

24. Nimrichter, L., S. Frases, L. P. Cinelli, N. B. Viana, A. Nakouzi, L. R. Travassos, A. Casadevall, and M. L. Rodrigues. 2007. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryot Cell 6:1400-10. 

25. Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. 2007. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitin-like structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell.  

26. Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, Almeida IC, Casadevall A. 2007. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence.Eukaryot Cell.  

27. Rodrigues, M. L., L. Nimrichter, D. L. Oliveira, S. Frases, K. Miranda, O. Zaragoza, M. Alvarez, A. Nakouzi, M. Feldmesser, and A. Casadevall. 2007. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6:48-59.  

28. Saha DC, Goldman DL, Shao X, Casadevall A, Husain S, Limaye AP, Lyon M, Somani J, Pursell K, Pruett TL, Singh N. 2007. Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.Clin Vaccine Immunol. 

29. Schweitzer, A. D., V. Rakesh, E. Revskaya, A. Datta, A. Casadevall, and E. Dadachova. 2007. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations. Melanoma Res 17:291-303.  

30. Torres M, Fernandez-Fuentes N, Fiser A, Casadevall A. 2007.Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity.PLoS ONE. 

31. Torres, M., N. Fernandez-Fuentes, A. Fiser, and A. Casadevall. 2007. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem 282:13917-27. 

32. Wang XG, Revskaya E, Bryan RA, Strickler HD, Burk RD, Casadevall A, Dadachova E. 2007. Treating cancer as an infectious disease-viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology.PLoS ONE.  

33. Zaragoza, O., M. Alvarez, A. Telzak, J. Rivera, and A. Casadevall. 2007. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect Immun 75:2729-39. 

34. Zhuang D, Hage C, De Jesus M, Hackett E, Durkin M, Davis TE, Casadevall A, Wheat LJ. 2007. Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay. Clin Vaccine Immunol.